New Visual Abstract: Subcutaneous or Transvenous Defibrillator Therapy
Subcutaneous or Transvenous Defibrillator Therapy.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Aug 2020 – May 2025Where it's discussed
-
X / Twitter134 posts
-
News9 articles
-
Facebook5 posts
-
Blogs4 articles
-
YouTube3 videos
AI synopsis
What people are saying
Several discussions prominently feature elements from the PRAETORIAN trial, such as the comparative rates of device complications and inappropriate shocks. Phrases like 'transforming ICD therapy' and 'essentially equivalent' demonstrate an enthusiastic tone towards S-ICDs, while critical assessments about the protocol changes and the implications of inappropriate shocks hint at a nuanced understanding of the study's limitations. The choice of language reflects a mix of optimism and caution, indicating a provocative but positive discourse.
Many participants express support for the findings, highlighting the benefits of S-ICDs in comparison to transvenous devices while acknowledging their limitations.
The discussions reveal a robust curiosity, with users frequently referencing significant trials such as PRAETORIAN to explore nuances of the study.
There's a deep engagement with the material, as evidenced by users analyzing trial protocols and device-related complications in detail.
While some view the research as impactful, others express ambivalence regarding the practicality of S-ICDs due to concerns over inappropriate shocks.
Abstract in brief
- The study compared the effectiveness of two types of implantable cardioverter-defibrillators (ICDs): subcutaneous and transvenous, focusing on device-related complications and inappropriate shocks.
- A total of 849 patients participated, showing that both groups experienced similar rates of primary end-point events over a median follow-up of 49.1 months, confirming noninferiority of the subcutaneous ICD.
- Device-related complications were less frequent in the subcutaneous group, but they had more inappropriate shocks and a higher mortality rate compared to the transvenous group.
Top posts
Most liked on X and BlueskyIn patients with an indication for an ICD but no indication for pacing, the subcutaneous ICD was noninferior to the transvenous ICD with respect to device-related complications and inappropriate shocks. https://t.co/M3zIlhystt
#EHRAtopicweek on non-Transvenous ICDs! ⚡️ S-ICDs are transforming ICD therapy by providing lifesaving protection without the need for venous access & reduce lead fractures, insulation defects, and infection Learn more on #PREATORIAN trial
最新号のNEJMから ICD適応(ペーシング不要)に対して、S-ICD/TV-ICDでRCT 非劣性試験 結果は非劣性 基礎疾患によってはCRTへのupgradeなどもあるので慎重に見ないといけないけど、より一層広がりそうですね Subcutaneous or Transvenous Defibrillator Therapy | NEJM https://t.co/zEBIouBZ00
Visual Abstract: Subcutaneous or Transvenous Defibrillator Therapy
In PRAETORIAN, the mean implant time for S-ICD implants was only 5 minutes longer than TV-ICD implants (55 min vs 50 min). Read the full results here: @NEJM @KnopsReinoud #SCD #SICDFirst https://t.co/HVJJDRURDI https://t.co/jjUbeyRYo0
All mentions
FDA Approves TAVR for Asymptomatic Aortic Stenosis Patients
The FDA approval of TAVR for patients with asymptomatic Aortic Stenosis is discussed. Additionally, the video covers a study comparing subcutaneous and transvenous ICDs, highlighting device-related complications and…
Comparison of Subcutaneous vs Transvenous ICDs in Cardiology
This week, John Mandrola MD discusses the effectiveness of subcutaneous and transvenous implantable cardioverter-defibrillators (ICDs). The study shows similar rates of end-point events but highlights fewer…
Critical Analysis of Outcome Data in Stroke Treatment Meta-Analysis
This study conducted a methodological survey of a meta-analysis on alteplase treatment for ischemic stroke, specifically focusing on the issue of missing outcome data. It highlights the potential bias introduced by…
RT @EHRAPresident: #EHRAtopicweek on non-Transvenous ICDs! ⚡️ S-ICDs are transforming ICD therapy by providing lifesaving protection witho…
RT @EHRAPresident: #EHRAtopicweek on non-Transvenous ICDs! ⚡️ S-ICDs are transforming ICD therapy by providing lifesaving protection witho…
#EHRAtopicweek on non-Transvenous ICDs! ⚡️ S-ICDs are transforming ICD therapy by providing lifesaving protection without the need for venous access & reduce lead fractures, insulation defects, and infection Learn more on #PREATORIAN trial
RT @AnneNeubert1: 5/ Subcutaneous or Transvenous Defibrillator Therapy - Reinoud E Knops https://t.co/zso13u367b
5/ Subcutaneous or Transvenous Defibrillator Therapy - Reinoud E Knops https://t.co/zso13u367b
The 'essentially equivalent' label comes from the PRAETORIAN non-inferiority trial that compared TV-ICD to SQ-ICD. B/c the sq-icd means no lead in the heart, the ability of the device to diagnose the right rhythm became poorer.. https://t.co/sNaYC10Uqn
Open Access UCL Research: Subcutaneous or Transvenous Defibrillator Therapy https://t.co/w4o5o6xnd3
RT @nishiki8885: シンポジウム10 ・S-ICDとTV-ICDの比較に関しては ✔︎ PRAETORIAN Trial (NEJM2020) https://t.co/dhc2Pm2gcf ✔︎ Untouched trial (Circulation2021)…
RT @nishiki8885: シンポジウム10 ・S-ICDとTV-ICDの比較に関しては ✔︎ PRAETORIAN Trial (NEJM2020) https://t.co/dhc2Pm2gcf ✔︎ Untouched trial (Circulation2021)…
RT @nishiki8885: シンポジウム10 ・S-ICDとTV-ICDの比較に関しては ✔︎ PRAETORIAN Trial (NEJM2020) https://t.co/dhc2Pm2gcf ✔︎ Untouched trial (Circulation2021)…
RT @nishiki8885: シンポジウム10 ・S-ICDとTV-ICDの比較に関しては ✔︎ PRAETORIAN Trial (NEJM2020) https://t.co/dhc2Pm2gcf ✔︎ Untouched trial (Circulation2021)…
シンポジウム10 ・S-ICDとTV-ICDの比較に関しては ✔︎ PRAETORIAN Trial (NEJM2020) https://t.co/dhc2Pm2gcf ✔︎ Untouched trial (Circulation2021) https://t.co/9yp2XmMOcU を押さえておきましょう。 胸骨下植込みICD(EV -ICD)も今後登場するとか。 https://t.co/KrBTl14Jo6 #21JCS @JCIRC_IPR
RT @RFRedberg: PRAETORIAN authors considered shocks for oversensing of VT as appropriate, unlikely patients feel that way. Especially as a…
RT @RFRedberg: Original trial protocol for PRAETORIAN defined appropriate shocks as those for VT>180. If this endpoint definition hadn't be…
RT @RFRedberg: Original trial protocol for PRAETORIAN defined appropriate shocks as those for VT>180. If this endpoint definition hadn't be…
Original trial protocol for PRAETORIAN defined appropriate shocks as those for VT>180. If this endpoint definition hadn't been changed after trial started, SICD clearly inferior to transvenous. @HRSonline Subcutaneous or Transvenous Defibrillator Therapy |https://t.co/RB0WivM0Gr
PRAETORIAN authors considered shocks for oversensing of VT as appropriate, unlikely patients feel that way. Especially as any shock is associated with higher mortality. Subcutaneous or Transvenous Defibrillator Therapy | NEJM https://t.co/i5t1EE8bZd
PRAETORIAN Trial Subcutaneous or Transvenous Defibrillator Therapy https://t.co/PLLoV5MjVd https://t.co/IFyTPxXpap
血培陽性で抜去を悩むことが減るのでしょうか。皮下植込み型ICD。 Subcutaneous or Transvenous Defibrillator Therapy | NEJM https://t.co/KDBCvUKJrO https://t.co/d4c0eC7sRz
RT @KnopsReinoud: Full results of the Praetorian Trial now published in The NEJM: https://t.co/nxL37H2UL5
RT @Lguevaramath: Subcutaneous or Transvenous Defibrillator Therapy | NEJM https://t.co/M57Ux2lKfz @mencardio @torresviera @rigotordoc @je…
RT @Lguevaramath: Subcutaneous or Transvenous Defibrillator Therapy | NEJM https://t.co/M57Ux2lKfz @mencardio @torresviera @rigotordoc @je…
RT @Lguevaramath: Subcutaneous or Transvenous Defibrillator Therapy | NEJM https://t.co/M57Ux2lKfz @mencardio @torresviera @rigotordoc @je…
RT @Lguevaramath: Subcutaneous or Transvenous Defibrillator Therapy | NEJM https://t.co/M57Ux2lKfz @mencardio @torresviera @rigotordoc @je…
RT @Lguevaramath: Subcutaneous or Transvenous Defibrillator Therapy | NEJM https://t.co/M57Ux2lKfz @mencardio @torresviera @rigotordoc @je…
RT @Lguevaramath: Subcutaneous or Transvenous Defibrillator Therapy | NEJM https://t.co/M57Ux2lKfz @mencardio @torresviera @rigotordoc @je…
RT @Lguevaramath: Subcutaneous or Transvenous Defibrillator Therapy | NEJM https://t.co/M57Ux2lKfz @mencardio @torresviera @rigotordoc @je…
RT @Lguevaramath: Subcutaneous or Transvenous Defibrillator Therapy | NEJM https://t.co/M57Ux2lKfz @mencardio @torresviera @rigotordoc @je…
Subcutaneous or Transvenous Defibrillator Therapy | NEJM https://t.co/M57Ux2lKfz @mencardio @torresviera @rigotordoc @jesusrmujica @ernestocardio @jstragazue @recetario1
RT @KnopsReinoud: @BSC_EU_Heart @LluisMont2 A5: Yes! The subgroup analysis for primary vs secondary prevention showed NO difference in PRAE…
@BSC_EU_Heart @LluisMont2 A5: Yes! The subgroup analysis for primary vs secondary prevention showed NO difference in PRAETORIAN. Read the full PRAETORIAN study here: https://t.co/EnT2TbmabE #UseHeart @drsuneet @DrRoderickTung
本日の抄読会。うちはかなりS-ICD入れてるんですよね Subcutaneous or Transvenous Defibrillator Therapy | NEJM https://t.co/lJWya4QWL3
Subcutaneous or Transvenous Defibrillator Therapy? https://t.co/amZA7Tn965 @NEJM #cardiotwitter #ICD
RT @bernardowise: Subcutaneous #ICD Noninferior To Transvenous ICD For Device-Related Complications and Incidence Of Inappropriate Shocks #…
Subcutaneous #ICD Noninferior To Transvenous ICD For Device-Related Complications and Incidence Of Inappropriate Shocks #EPeeps - #SCD https://t.co/mCbLIg7zr7
Subcutaneous or Transvenous Defibrillator Therapy https://t.co/w8KsIXkWGz #cardiology
RT @BSCCardiology: Now published in @NEJM: The PRAETORIAN Trial represents the first prospective, randomized head-to-head clinical trial de…
Now published in @NEJM: The PRAETORIAN Trial represents the first prospective, randomized head-to-head clinical trial demonstrating non-inferiority between the S-ICD and TV-ICDs. NEJM [sub. required]: https://t.co/a49dEDvMPL PRAETORIAN Trial data: https://t.co/HZEqaLxJeQ https://t.co/a3zn3eMMsw
The @NEJM has published the PRAETORIAN Trial results, which compared the S-ICD with TV-ICDs in a landmark clinical trial. NEJM [subscription required]: https://t.co/TztNXXFw0X PRAETORIAN Trial data: https://t.co/gqncFRdncg https://t.co/zUGX75H15T
RT @jvillacastin: In patients with an indication for an ICD but no indication for pacing, the subcutaneous ICD was noninferior to the trans…
RT @jvillacastin: In patients with an indication for an ICD but no indication for pacing, the subcutaneous ICD was noninferior to the trans…
Terapia desfibriladora subcutánea o transvenosa https://t.co/0i9yW08oGr PMID 32757521
RT @jvillacastin: In patients with an indication for an ICD but no indication for pacing, the subcutaneous ICD was noninferior to the trans…
RT @jvillacastin: In patients with an indication for an ICD but no indication for pacing, the subcutaneous ICD was noninferior to the trans…
RT @jvillacastin: In patients with an indication for an ICD but no indication for pacing, the subcutaneous ICD was noninferior to the trans…
RT @jvillacastin: In patients with an indication for an ICD but no indication for pacing, the subcutaneous ICD was noninferior to the trans…
RT @jvillacastin: In patients with an indication for an ICD but no indication for pacing, the subcutaneous ICD was noninferior to the trans…
In patients with an indication for an ICD but no indication for pacing, the subcutaneous ICD was noninferior to the transvenous ICD with respect to device-related complications and inappropriate shocks. https://t.co/M3zIlhystt
Subcutaneous ICD noninferior to transvenous ICD: Subcutaneous or Transvenous Defibrillator Therapy | comment: Gust H Bardy MD https://t.co/6dfaaR0I7z via @practiceupdate
RT @hcg_md: Subcutaneous or Transvenous Defibrillator Therapy - this RCT found non-inferiority between subcutaneous and transvenous devices…
Subcutaneous or Transvenous Defibrillator Therapy - this RCT found non-inferiority between subcutaneous and transvenous devices with regard to device-related complications and inappropriate shocks. | @NEJM #EPeeps https://t.co/mULJO3Mb1M
RT @EJSMD: Congrats to @KnopsReinoud, @melchami99 @drsuneet and all investigators for pub of randomized PRAETORIAN trial — S-ICD was shown…
RT @EJSMD: Congrats to @KnopsReinoud, @melchami99 @drsuneet and all investigators for pub of randomized PRAETORIAN trial — S-ICD was shown…
RT @BSCCardiology: Full PRAETORIAN Trial data has been released and published in @NEJM. View safety and efficacy data comparing the S-ICD t…
RT @BSCCardiology: Full PRAETORIAN Trial data has been released and published in @NEJM. View safety and efficacy data comparing the S-ICD t…
RT @BSCCardiology: Full PRAETORIAN Trial data has been released and published in @NEJM. View safety and efficacy data comparing the S-ICD t…
Full PRAETORIAN Trial data has been released and published in @NEJM. View safety and efficacy data comparing the S-ICD to TV-ICDs in this pivotal clinical trial. NEJM [subscription required]: https://t.co/CA4s9U5HUi PRAETORIAN Trial data: https://t.co/OSXcsQsaN2 https://t.co/GRLzpOKcjv
https://t.co/hs7Enk00A8 S-ICDとTV-ICD、ランダム化前向き試験で非劣勢
RT @NEJM: Visual Abstract: Subcutaneous or Transvenous Defibrillator Therapy
RT @BSC_EU_Heart: No significant difference in inappropriate shock rates, with very low one-year rates at 4.1% in the TV-ICD group and 4.8%…
Ein Defi, bei dem die Sonden im Unterhautfettgewebe liegen, ist nicht schlechter als ein Defi, bei dem die Sonden im Herz platziert werden https://t.co/hWfKDIgU0C
RT @BSC_EU_Heart: No significant difference in inappropriate shock rates, with very low one-year rates at 4.1% in the TV-ICD group and 4.8%…
RT @BSC_EU_Heart: No significant difference in inappropriate shock rates, with very low one-year rates at 4.1% in the TV-ICD group and 4.8%…
RT @BSC_EU_Heart: No significant difference in inappropriate shock rates, with very low one-year rates at 4.1% in the TV-ICD group and 4.8%…
No significant difference in inappropriate shock rates, with very low one-year rates at 4.1% in the TV-ICD group and 4.8% for the S-ICD group: the full results of the PRAETORIAN trial are now available online: https://t.co/HVJJDRURDI @NEJM @KnopsReinoud #SCD #SICDFirst https://t.co/S34DbTT208
RT @BSC_EU_Heart: In PRAETORIAN, the mean implant time for S-ICD implants was only 5 minutes longer than TV-ICD implants (55 min vs 50 min…
RT @NEJM: Visual Abstract: Subcutaneous or Transvenous Defibrillator Therapy
RT @NEJM: Visual Abstract: Subcutaneous or Transvenous Defibrillator Therapy
RT @NEJM: Visual Abstract: Subcutaneous or Transvenous Defibrillator Therapy
RT @NEJM: Visual Abstract: Subcutaneous or Transvenous Defibrillator Therapy
RT @NEJM: Visual Abstract: Subcutaneous or Transvenous Defibrillator Therapy
Visual Abstract: Subcutaneous or Transvenous Defibrillator Therapy
RT @BSC_EU_Heart: In PRAETORIAN, the mean implant time for S-ICD implants was only 5 minutes longer than TV-ICD implants (55 min vs 50 min…
Subcutaneous or Transvenous Defibrillator Therapy | NEJM https://t.co/StYdhmXyTv
RT @BSC_EU_Heart: In PRAETORIAN, the mean implant time for S-ICD implants was only 5 minutes longer than TV-ICD implants (55 min vs 50 min…
In PRAETORIAN, the mean implant time for S-ICD implants was only 5 minutes longer than TV-ICD implants (55 min vs 50 min). Read the full results here: @NEJM @KnopsReinoud #SCD #SICDFirst https://t.co/HVJJDRURDI https://t.co/jjUbeyRYo0
RT @ArashArya_EP: #EPeeps Subcutaneous or Transvenous Defibrillator Therapy | NEJM https://t.co/6gR5F3t42k
#EPeeps Subcutaneous or Transvenous Defibrillator Therapy | NEJM https://t.co/6gR5F3t42k
RT @BSC_EU_Heart: Looking for your weekend reading? The full PRAETORIAN trial results are now available in @NEJM, click here to read the co…
RT @KnopsReinoud: Full results of the Praetorian Trial now published in The NEJM: https://t.co/nxL37H2UL5
RT @NEJM: New Visual Abstract: Subcutaneous or Transvenous Defibrillator Therapy
RT @NEJM: New Visual Abstract: Subcutaneous or Transvenous Defibrillator Therapy
Subcutaneous or Transvenous Defibrillator Therapy | NEJM https://t.co/E6O0meim7t
RT @NEJM: New Visual Abstract: Subcutaneous or Transvenous Defibrillator Therapy
RT @NEJM: New Visual Abstract: Subcutaneous or Transvenous Defibrillator Therapy
RT @NEJM: New Visual Abstract: Subcutaneous or Transvenous Defibrillator Therapy
RT @NEJM: New Visual Abstract: Subcutaneous or Transvenous Defibrillator Therapy
RT @NEJM: New Visual Abstract: Subcutaneous or Transvenous Defibrillator Therapy
RT @NEJM: New Visual Abstract: Subcutaneous or Transvenous Defibrillator Therapy
RT @NEJM: New Visual Abstract: Subcutaneous or Transvenous Defibrillator Therapy
RT @NEJM: New Visual Abstract: Subcutaneous or Transvenous Defibrillator Therapy
RT @NEJM: New Visual Abstract: Subcutaneous or Transvenous Defibrillator Therapy
RT @NEJM: New Visual Abstract: Subcutaneous or Transvenous Defibrillator Therapy
RT @NEJM: New Visual Abstract: Subcutaneous or Transvenous Defibrillator Therapy
New Visual Abstract: Subcutaneous or Transvenous Defibrillator Therapy
RT @KnopsReinoud: Full results of the Praetorian Trial now published in The NEJM: https://t.co/nxL37H2UL5
RT @DrJeilan: #PRAETORIAN subCut ICD vs transvenous ICD. SQ: fewer device complications; SQ: more inappropr shocks; SQ more death (19.3% vs…
#PRAETORIAN subCut ICD vs transvenous ICD. SQ: fewer device complications; SQ: more inappropr shocks; SQ more death (19.3% vs. 16.0% p=not significant ; not sudden; death not part of prmry endpoint) @BHRSociety @HRSonline @JACCJournals @NEJM @AFHRA_Cardio https://t.co/h3pqt79Uqv
RT @BSCCardiology: The @NEJM has published the PRAETORIAN Trial results, which compared the S-ICD with TV-ICDs in a landmark clinical trial…
RT @KnopsReinoud: Full results of the Praetorian Trial now published in The NEJM: https://t.co/nxL37H2UL5
RT @BSCCardiology: The @NEJM has published the PRAETORIAN Trial results, which compared the S-ICD with TV-ICDs in a landmark clinical trial…
RT @BSCCardiology: Now published in @NEJM: The PRAETORIAN Trial represents the first prospective, randomized head-to-head clinical trial de…
RT @BSCCardiology: The @NEJM has published the PRAETORIAN Trial results, which compared the S-ICD with TV-ICDs in a landmark clinical trial…
RT @BSCCardiology: Now published in @NEJM: The PRAETORIAN Trial represents the first prospective, randomized head-to-head clinical trial de…
RT @KnopsReinoud: Full results of the Praetorian Trial now published in The NEJM: https://t.co/nxL37H2UL5
RT @BSCCardiology: Now published in @NEJM: The PRAETORIAN Trial represents the first prospective, randomized head-to-head clinical trial de…
RT @BSC_EU_Heart: Looking for your weekend reading? The full PRAETORIAN trial results are now available in @NEJM, click here to read the co…
Looking for your weekend reading? The full PRAETORIAN trial results are now available in @NEJM, click here to read the complete publication: https://t.co/HVJJDRURDI @KnopsReinoud #SCD #SICDFirst https://t.co/Z3DDt18Dn9
Subcutaneous or Transvenous Defibrillator Therapy | NEJM https://t.co/bUe8ITganq
RT @BSCCardiology: The @NEJM has published the PRAETORIAN Trial results, which compared the S-ICD with TV-ICDs in a landmark clinical trial…
RT @KnopsReinoud: Full results of the Praetorian Trial now published in The NEJM: https://t.co/nxL37H2UL5
RT @BSCCardiology: The @NEJM has published the PRAETORIAN Trial results, which compared the S-ICD with TV-ICDs in a landmark clinical trial…
RT @BSC_EU_Heart: ICYMI: The full PRAETORIAN results have been published in @NEJM, demonstrating that the S-ICD offers comparable performan…
RT @BSC_EU_Heart: ICYMI: The full PRAETORIAN results have been published in @NEJM, demonstrating that the S-ICD offers comparable performan…
RT @KnopsReinoud: Full results of the Praetorian Trial now published in The NEJM: https://t.co/nxL37H2UL5
RT @jvillacastin: In patients with an indication for an ICD but no indication for pacing, the subcutaneous ICD was noninferior to the trans…
RT @KnopsReinoud: Full results of the Praetorian Trial now published in The NEJM: https://t.co/nxL37H2UL5
RT @KnopsReinoud: Full results of the Praetorian Trial now published in The NEJM: https://t.co/nxL37H2UL5
RT @BSC_EU_Heart: ICYMI: The full PRAETORIAN results have been published in @NEJM, demonstrating that the S-ICD offers comparable performan…
ICD but no pacing, subcutaneous ICD was noninferior to the transvenous ICD with respect to device-related complications and inappropriate shocks. https://t.co/zAAPvczNfa https://t.co/h8egz2sMAY
RT @BSC_EU_Heart: Today in @NEJM: Full results of the PRAETORIAN trial of Subcutaneous vs Transvenous Defibrillator Therapy, confirming tha…
RT @KnopsReinoud: Full results of the Praetorian Trial now published in The NEJM: https://t.co/nxL37H2UL5
RT @jvillacastin: In patients with an indication for an ICD but no indication for pacing, the subcutaneous ICD was noninferior to the trans…
RT @BSC_EU_Heart: Today in @NEJM: Full results of the PRAETORIAN trial of Subcutaneous vs Transvenous Defibrillator Therapy, confirming tha…
RT @EJSMD: Congrats to @KnopsReinoud, @melchami99 @drsuneet and all investigators for pub of randomized PRAETORIAN trial — S-ICD was shown…
RT @KnopsReinoud: Full results of the Praetorian Trial now published in The NEJM: https://t.co/nxL37H2UL5
RT @Links_Medicus: [Abstract only] Randomized trial: Subcutaneous vs. transvenous defibrillator therapy – via @NEJM https://t.co/JZ2SiNGQb…
RT @KnopsReinoud: Full results of the Praetorian Trial now published in The NEJM: https://t.co/nxL37H2UL5
RT @EJSMD: Congrats to @KnopsReinoud, @melchami99 @drsuneet and all investigators for pub of randomized PRAETORIAN trial — S-ICD was shown…
RT @Links_Medicus: [Abstract only] Randomized trial: Subcutaneous vs. transvenous defibrillator therapy – via @NEJM https://t.co/JZ2SiNGQb…
RT @Yuki_Sahashi: 最新号のNEJMから ICD適応(ペーシング不要)に対して、S-ICD/TV-ICDでRCT 非劣性試験 結果は非劣性 基礎疾患によってはCRTへのupgradeなどもあるので慎重に見ないといけないけど、より一層広がりそうですね Subc…
RT @Yuki_Sahashi: 最新号のNEJMから ICD適応(ペーシング不要)に対して、S-ICD/TV-ICDでRCT 非劣性試験 結果は非劣性 基礎疾患によってはCRTへのupgradeなどもあるので慎重に見ないといけないけど、より一層広がりそうですね Subc…
RT @Yuki_Sahashi: 最新号のNEJMから ICD適応(ペーシング不要)に対して、S-ICD/TV-ICDでRCT 非劣性試験 結果は非劣性 基礎疾患によってはCRTへのupgradeなどもあるので慎重に見ないといけないけど、より一層広がりそうですね Subc…
最新号のNEJMから ICD適応(ペーシング不要)に対して、S-ICD/TV-ICDでRCT 非劣性試験 結果は非劣性 基礎疾患によってはCRTへのupgradeなどもあるので慎重に見ないといけないけど、より一層広がりそうですね Subcutaneous or Transvenous Defibrillator Therapy | NEJM https://t.co/zEBIouBZ00
N
JV
E
YS
BC
DE
DT
U
AN
AM
UD
高心
り
色ガ
日情
KN
D
ME
RR
KC
官H
JB
EE
JM
RV
IM
DC
EH
FR
ZC
LM
M
RK
小K
DM
EB
BM
C
M
BC
HR
RM
NP
D
BS
A
MB
HM
H
KM
DE
SM
JM
循
PS
SU
KI
DB
MT
TK
LC
UR
MJ
ひ循
ZP
PM
SA
MK
AA
HC
EM
JM
DM
PL
K
LP
B
DS
CA
S
?
JT
JP
TJ
JD
BS
B
LC
PM
CW
BI
L
I
EB
HC
DR
AB
ML
NS
MG
DM
GL
AB
MG
Y
H佐
Tね